Leveraging 130 years of knowledge and expertise across the Johnson & Johnson Family of Companies, Johnson & Johnson Medical Devices (JJMD) is proud to launch a new approach to help drive value-based healthcare in hospitals across Europe, Middle East and Africa (EMEA) – CareAdvantage. This is a data-driven, holistic approach in which JJMD partners with hospitals and other healthcare providers to provide a range of benefits, tailored to the customer’s specific needs and priorities.
The healthcare marketplace is changing, with intensifying pressure to meet the ‘triple aim’ of improving outcomes, increasing patient satisfaction and reducing costs. As the focus shifts from volume to value, there is a growing need for new delivery models, resulting in rapid transformation for hospital systems, clinicians and their patients.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8119051-johnson-medical-devices-careadvantage/
Progresso is now using only 100 percent antibiotic and hormone free chicken breasts in all of its 36 chicken soup varieties. Currently available on store shelves nationwide, Progresso is the first large retail soup brand in the United States to have antibiotic and hormone free chicken breasts in its soups.
For decades, Progresso has been committed to continuously improving the quality of its soups. Not only is Progresso now using only white breast meat chicken with no antibiotics or hormones, but the brand is also free from artificial flavors and has removed artificial colors from 60 percent of its soups, with a goal to remove 100 percent by 2019. In addition, the soup brand has reduced sodium levels in more than 40 soup varieties, added seven soups to its certified Gluten Free product line and is increasing its vegetarian soup options.
To view the multimedia release go to:
http://www.multivu.com/players/English/7885251-progresso-antibiotic-free-chicken/
Educators engage with the most vulnerable populations and good intentions aren’t enough to drive decisions. Ethics goes beyond a simple right vs. wrong and there is a clear and compelling gap in educators’ professional continuum. Now, the research-based ProEthica™ program offers educators techniques and strategies for improving awareness of professional risks and vulnerabilities, and for the application of professional ethics in daily decision making.
Developed by Educational Testing Service (ETS), the ProEthica online educator ethics training program is research-based and designed for teachers and educational leaders. Through a series of interactive modules that combine instruction and checks for understanding, the ProEthica program uses real-life scenario-based simulations and activities to help educators establish an understanding of ethical principles and decision making, and learn how to apply them in their daily practice.
To view the multimedia release go to:
http://www.multivu.com/players/English/7798251-ets-proethica-teacher-training/
INRIX®, Inc., a global leader for transportation analytics, today released its 2015 Traffic Scorecard, a benchmark for governments and agencies in the U.S. and Europe to measure progress in improving urban mobility.
The report reveals the U.S. faces large challenges to solve congestion issues, fueled by continued economic and population growth, higher employment rates and declining gas prices. Cities that have experienced the most economic improvement during the past year are at highest risk for consequences related to worsened traffic conditions, including reduced productivity, higher emissions and increased stress levels. For example, Washington D.C., San Francisco, New York, Seattle and Boston all saw reduced unemployment rates bringing them below the national average of 5.3 percent for 2015.1 However, according to the INRIX Traffic Scorecard, congestion in those cities alone combined to waste 1.5 billion hours for daily car commuters last year. Nationwide, commuters spent a total of more than eight billion extra hours stuck in traffic, representing almost 50 hours per driver.
To view the multimedia release go to:
http://www.multivu.com/players/English/7775551-inrix-2015-traffic-scorecard/
Today, the American Immigration Lawyers Association (AILA) issued a report card on President Obama's immigration efforts over the past seven years and made recommendations for how to reform immigration in his last year.
“In recent days and weeks he has shown leadership in protecting refugees from Syria,” said AILA President Victor Nieblas Pradis. “But until recently, the president's response was timid and he still plans to resettle only 10,000 Syrian refugees this year. He can save many more lives by setting his target at 100,000 Syrian refugees.”
“In our own hemisphere, when Central American individuals and families, including young children, arrived at our southern border seeking refuge from the horrific violence plaguing those countries, the president should have protected them, but instead, he treated them as a border threat. The president should acknowledge that the situation in Central America is a humanitarian crisis and use every tool at his disposal to protect those fleeing. Most important he should stop detaining thousands of families.”
“The reforms to the legal immigration system he promised a year ago have moved forward at a glacial pace, earning him an incomplete. He can benefit the economy enormously by implementing plans to encourage research, development and entrepreneurial start-ups.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7683151-aila-national-immigration-report-card/
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer. The study from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project appears in the November 19 edition of the New England Journal of Medicine.
Ultimately, researchers anticipate that systematic monitoring of patients and family members who have germline mutations in cancer predisposition genes will allow the detection of cancers at their earliest and most curable stage, thereby improving the outcomes for these children and family members.
To view the multimedia release go to:
http://www.multivu.com/players/English/7692851-st-jude-hospital-genome-project/
Kia Motors America (KMA) today unveiled the all-new 2017 Sportage at the Los Angeles Auto Show. The fourth-generation Sportage, KMA’s longest-running nameplate, wraps stunning contemporary design around a structure that is both stiffer and more spacious than before. Advanced driver assistance technologies, significant suspension and steering improvements, and available intelligent AWD vastly improve the Sportage’s driving dynamics while premium materials and world-class craftsmanship create a class-up experience in an otherwise utilitarian segment.
“Simply put, the Sportage is a breed apart in the compact CUV segment,” said Orth Hedrick, vice president, product planning KMA. “Instead of bland utility, the Sportage combines distinctly European and sporty styling with thoughtful design and functionality, including innovative packaging, premium materials, a turbocharged engine and surprising features. Sales of compact CUVs are on a sharply upward trajectory, and the all-new 2017 Sportage hits the sweet spot by providing an alternative for those seeking to express themselves with a vehicle that’s versatile enough to suit their unique lifestyle.”
The all-new Sportage’s roomier, more luxurious cabin features an impressive level of craftsmanship, with high-quality, soft-touch materials and a range of technologies improving overall comfort, convenience, and connectivity. Updates to the drivetrain provide enhanced efficiency and performance, while changes to the suspension deliver better ride and handling. Like the outgoing model, the all-new Sportage will be built at Kia’s production facility in Gwangju, Korea, and be available in three distinct trim levels (LX, EX, SX Turbo) when it goes on sale next year. Pricing will be announced closer to the Sportage’s on-sale date.
To view the multimedia release go to:
http://www.multivu.com/players/English/7436354-2017-kia-sportage-l-a-auto-show-debut/
Utica College President Todd S. Hutton announced today that the College is resetting the on-campus undergraduate tuition price beginning Fall 2016. The new tuition price will be under $20,000, and the college will continue to offer both need-based and merit-based financial aid to lower the cost to qualified students and their families even further.
“We consider this tuition reset to be a bold move for tomorrow,” Dr. Hutton says, “because in improving affordability, we are also expanding access to a high quality Utica College education that launches our students’ successful futures.”
The tuition reset comes at a time when private colleges and universities throughout the nation are taking a hard look at their pricing system. Many college-bound students and their families do not realize that the full price will likely be deeply discounted for them by a private college, and so they experience “sticker shock” upon seeing the published price.
To view the multimedia release go to:
http://www.multivu.com/players/English/7624151-utica-college-resets-tuition/
Global health service company Cigna has added three new programs to the free Coach by Cigna health and fitness app, featuring coaching tips from The Fit Bottomed Girls for The Anti-Diet, Loving Yourself and Top to Bottom fitness.
The Coach by Cigna app puts health and fitness programs in the palm of your hand, with instructional videos and support from health coaches to help you focus on improving in five integrated areas: nutrition, exercise, sleep, stress and weight management.
To view the multimedia release go to:
http://www.multivu.com/players/English/7448831-coach-by-cigna-fitness-app/
The Leukemia & Lymphoma Society (LLS), the world’s leading voluntary non-profit dedicated to blood cancers, released 30 “proof points” - one for each day of September, Blood Cancer Awareness Month - to demonstrate its impact on the cancer landscape and progress towards a world without blood cancers.
LLS has invested more than $1 billion in research to advance breakthrough therapies and cures for blood cancer patients. In many cases, those treatments are now helping patients with other cancers and chronic diseases. Due to its focus on blood cancers, survival rates are improving. Since the early 1960s, five-year survival rates for many blood cancer patients have doubled, tripled and even quadrupled.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554851-lls-blood-cancer-awareness-month/
Johnson Controls, a global multi-industrial company, is constantly focusing on improving the future of car seating. Thinking ahead, Johnson Controls will present its seating demonstrator vehicle SD15 to customers and media at the 66th Frankfurt Autoshow. The SD15 features a simulated vehicle environment with a focus on first- and second-row seating while addressing the three automotive megatrends from a seating perspective: autonomous driving, lightweight, and increasing customer demands towards individualization and style for future urban mobility.
Furthermore, the stylish ink jet printed seat covers of the SD15 show what Johnson Controls can do in terms of individualization. The weight and space saving multi-material seats padded with highly ergonomic foam parts pave the way towards the demands of lightweight design. Many SD15 features support the megatrend of autonomous driving in the future “multi-talented” vehicle seat.
The SD15’s front row features a power driver seat mounted to a curved track, eliminating the need for separate and complex mechanisms found in conventional seat arrangements. The seat offers a control console mounted directly to the seat structure that moves conveniently with the occupant, instead of being fixed between the seats which offers wireless charging options for mobile devices.
To view the multimedia release visit:
http://www.multivu.com/players/uk/7592351-johnson-controls-new-SD15-seating-vehicle/
Johnson Controls, a global multi-industrial company, is constantly focusing on improving the future of car seating. Thinking ahead, Johnson Controls will present its seating demonstrator vehicle SD15 to customers and media at the 66th Frankfurt Autoshow. The SD15 features a simulated vehicle environment with a focus on first- and second-row seating while addressing the three automotive megatrends from a seating perspective: autonomous driving, lightweight, and increasing customer demands towards individualization and style for future urban mobility.
“The SD15 is based on extensive proprietary research conducted by Johnson Controls that explored what consumers expect as car seating in 2020 and beyond,” said Beda Bolzenius, president of Johnson Controls Automotive Experience. “The driver side demonstrates superior comfort and the passenger side showcases features that maximize cargo capacity and interior flexibility.”
To view the multimedia release visit:
http://www.multivu.com/players/uk/7592351-johnson-controls-new-SD15-seating-vehicle/
